| EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection P Lampertico, K Agarwal, T Berg, M Buti, HLA Janssen, ... Journal of hepatology 67 (2), 370-398, 2017 | 5172 | 2017 |
| A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness L Stuyver, S De Gendt, C Van Geyt, F Zoulim, M Fried, RF Schinazi, ... Journal of general virology 81 (1), 67-74, 2000 | 1502 | 2000 |
| Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases LP Jordheim, D Durantel, F Zoulim, C Dumontet Nature reviews Drug discovery 12 (6), 447-464, 2013 | 1396 | 2013 |
| Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy B Werle–Lapostolle, S Bowden, S Locarnini, K Wursthorn, J Petersen, ... Gastroenterology 126 (7), 1750-1758, 2004 | 1229 | 2004 |
| Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019 | 1213 | 2019 |
| Statements from the Taormina expert meeting on occult hepatitis B virus infection G Raimondo, JP Allain, MR Brunetto, MA Buendia, DS Chen, M Colombo, ... Journal of hepatology 49 (4), 652-657, 2008 | 1160 | 2008 |
| EASL Clinical Practice Guidelines: management of hepatitis C virus infection European Association For The Study Of The Liver Journal of hepatology 60 (2), 392-420, 2014 | 1001 | 2014 |
| Hepatitis B virus resistance to nucleos (t) ide analogues F Zoulim, S Locarnini Gastroenterology 137 (5), 1593-1608. e2, 2009 | 927 | 2009 |
| Antiviral drug‐resistant HBV: standardization of nomenclature and assays and recommendations for management AS Lok, F Zoulim, S Locarnini, A Bartholomeusz, MG Ghany, ... Hepatology 46 (1), 254-265, 2007 | 685 | 2007 |
| Woodchuck hepatitis virus X protein is required for viral infection in vivo F Zoulim, J Saputelli, C Seeger Journal of virology 68 (3), 2026-2030, 1994 | 625 | 1994 |
| Eradication of hepatitis C virus infection in patients with cirrhosis reduces risk of liver and non-liver complications P Nahon, V Bourcier, R Layese, E Audureau, C Cagnot, P Marcellin, ... Gastroenterology 152 (1), 142-156. e2, 2017 | 622 | 2017 |
| Hepatitis B cure: from discovery to regulatory approval AS Lok, F Zoulim, G Dusheiko, MG Ghany Hepatology 66 (4), 1296-1313, 2017 | 616 | 2017 |
| Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study F Carrat, H Fontaine, C Dorival, M Simony, C Hezode, V De Ledinghen, ... The Lancet 393 (10179), 1453-1464, 2019 | 596 | 2019 |
| Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study C Charlier, É Perrodeau, A Leclercq, B Cazenave, B Pilmis, B Henry, ... The Lancet Infectious Diseases 17 (5), 510-519, 2017 | 567 | 2017 |
| Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC)–NCT01514890 C Hézode, H Fontaine, C Dorival, D Larrey, F Zoulim, V Canva, ... Journal of hepatology 59 (3), 434-441, 2013 | 562 | 2013 |
| Therapeutic strategies for hepatitis B virus infection: towards a cure GC Fanning, F Zoulim, J Hou, A Bertoletti Nature reviews Drug discovery 18 (11), 827-844, 2019 | 560 | 2019 |
| Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection J Lucifora, S Arzberger, D Durantel, L Belloni, M Strubin, M Levrero, ... Journal of hepatology 55 (5), 996-1003, 2011 | 557 | 2011 |
| A placebo-controlled trial of bezafibrate in primary biliary cholangitis C Corpechot, O Chazouillères, A Rousseau, A Le Gruyer, F Habersetzer, ... New England Journal of Medicine 378 (23), 2171-2181, 2018 | 543 | 2018 |
| Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection C Bain, A Fatmi, F Zoulim, JP Zarski, C Trépo, G Inchauspé Gastroenterology 120 (2), 512-524, 2001 | 535 | 2001 |
| Report of an international workshop: roadmap for management of patients receiving oral therapy for chronic hepatitis B EB Keeffe, S Zeuzem, RS Koff, DT Dieterich, R Esteban–Mur, EJ Gane, ... Clinical Gastroenterology and Hepatology 5 (8), 890-897, 2007 | 501 | 2007 |
